Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Revolution Medicines
Biotech
EMD Serono taps in new commercial strategy head—Chutes & Ladders
EMD Serono taps in a new commercial strategy head. New Sanofi CEO swaps out research chief. RevMed R&D leader readies for retirement.
Darren Incorvaia
,
Zoey Becker
Jun 26, 2026 8:30am
ASCO: RevMed confident in RAS leadership as rivals square up
May 31, 2026 8:00am
AACR: Revolution rolls on in pancreatic cancer as RAS wave rises
Apr 21, 2026 5:35pm
Revolution’s RAS inhibitor hits key goals in ph. 3 cancer trial
Apr 13, 2026 8:00am
Small molecules are 'resurgent' in orphan drug R&D: Evaluate
Mar 12, 2026 10:30am
Takeda inks $1.7B AI discovery deal with Iambic Therapeutics
Feb 9, 2026 8:00am
